GSK at a glance

• Our mission is to improve the quality of human life by enabling people to do more, feel better and live longer
We are a research-based pharmaceutical company
• We are the only pharmaceutical company to tackle the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria
• Our business employs over 100,000 people in 117 countries
• We make almost four billion packs of medicines and healthcare products every year
• Over 15,000 people work in our research teams to discover new medicines
• We screen about 65 million compounds every year in our search for new medicines
• We supply one quarter of the world's vaccines and by the end of February 2007 we had 23 vaccines in clinical development
• In 2006 we donated 155 million albendazole tablets to help eliminate lymphatic filariasis (elephantiasis), making almost 600 million treatments in total
• In 2006 we shipped 206 million tablets of preferentially-priced Combivir and Epivir (our HIV treatments) to developing countries - including 120 million tablets supplied by generics manufacturers licensed by GSK
• In 2006 our global community investment was £302 million, 3.9% of profit before tax
• Many of our consumer brands are household names: Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums, Zovirax